Global Seasonal Influenza Vaccines Therapeutics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Seasonal Influenza Vaccines Therapeutics market report explains the definition, types, applications, major countries, and major players of the Seasonal Influenza Vaccines Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Hualun Biologicals

    • Novartis

    • CSL

    • Solvay

    • MedImmune

    • Sanofi-Pasteur

    • Sinovac Biotech

    • GSK

    By Type:

    • Paediatrics

    • Adolescence

    • Adults

    • Elderly

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Seasonal Influenza Vaccines Therapeutics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Seasonal Influenza Vaccines Therapeutics Outlook to 2028- Original Forecasts

    • 2.2 Seasonal Influenza Vaccines Therapeutics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Seasonal Influenza Vaccines Therapeutics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Seasonal Influenza Vaccines Therapeutics Market- Recent Developments

    • 6.1 Seasonal Influenza Vaccines Therapeutics Market News and Developments

    • 6.2 Seasonal Influenza Vaccines Therapeutics Market Deals Landscape

    7 Seasonal Influenza Vaccines Therapeutics Raw Materials and Cost Structure Analysis

    • 7.1 Seasonal Influenza Vaccines Therapeutics Key Raw Materials

    • 7.2 Seasonal Influenza Vaccines Therapeutics Price Trend of Key Raw Materials

    • 7.3 Seasonal Influenza Vaccines Therapeutics Key Suppliers of Raw Materials

    • 7.4 Seasonal Influenza Vaccines Therapeutics Market Concentration Rate of Raw Materials

    • 7.5 Seasonal Influenza Vaccines Therapeutics Cost Structure Analysis

      • 7.5.1 Seasonal Influenza Vaccines Therapeutics Raw Materials Analysis

      • 7.5.2 Seasonal Influenza Vaccines Therapeutics Labor Cost Analysis

      • 7.5.3 Seasonal Influenza Vaccines Therapeutics Manufacturing Expenses Analysis

    8 Global Seasonal Influenza Vaccines Therapeutics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Seasonal Influenza Vaccines Therapeutics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Seasonal Influenza Vaccines Therapeutics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Seasonal Influenza Vaccines Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Paediatrics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Adolescence Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Adults Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Elderly Consumption and Growth Rate (2017-2022)

    • 9.2 Global Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Seasonal Influenza Vaccines Therapeutics Market Analysis and Outlook till 2022

    • 10.1 Global Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.2.2 Canada Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.2.3 Mexico Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.2 UK Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.3 Spain Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.4 Belgium Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.5 France Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.6 Italy Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.7 Denmark Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.8 Finland Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.9 Norway Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.10 Sweden Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.11 Poland Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.12 Russia Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.3.13 Turkey Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.2 Japan Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.3 India Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.4 South Korea Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.5 Pakistan Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.6 Bangladesh Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.7 Indonesia Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.8 Thailand Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.9 Singapore Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.10 Malaysia Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.11 Philippines Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.4.12 Vietnam Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.5.2 Colombia Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.5.3 Chile Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.5.4 Argentina Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.5.5 Venezuela Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.5.6 Peru Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.5.8 Ecuador Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.6.2 Kuwait Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.6.3 Oman Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.6.4 Qatar Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.7.2 South Africa Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.7.3 Egypt Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.7.4 Algeria Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

      • 10.8.2 New Zealand Seasonal Influenza Vaccines Therapeutics Consumption (2017-2022)

    11 Global Seasonal Influenza Vaccines Therapeutics Competitive Analysis

    • 11.1 Hualun Biologicals

      • 11.1.1 Hualun Biologicals Company Details

      • 11.1.2 Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

      • 11.1.4 Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novartis

      • 11.2.1 Novartis Company Details

      • 11.2.2 Novartis Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

      • 11.2.4 Novartis Seasonal Influenza Vaccines Therapeutics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 CSL

      • 11.3.1 CSL Company Details

      • 11.3.2 CSL Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

      • 11.3.4 CSL Seasonal Influenza Vaccines Therapeutics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Solvay

      • 11.4.1 Solvay Company Details

      • 11.4.2 Solvay Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Solvay Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

      • 11.4.4 Solvay Seasonal Influenza Vaccines Therapeutics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 MedImmune

      • 11.5.1 MedImmune Company Details

      • 11.5.2 MedImmune Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 MedImmune Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

      • 11.5.4 MedImmune Seasonal Influenza Vaccines Therapeutics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sanofi-Pasteur

      • 11.6.1 Sanofi-Pasteur Company Details

      • 11.6.2 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

      • 11.6.4 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sinovac Biotech

      • 11.7.1 Sinovac Biotech Company Details

      • 11.7.2 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

      • 11.7.4 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 GSK

      • 11.8.1 GSK Company Details

      • 11.8.2 GSK Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 GSK Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

      • 11.8.4 GSK Seasonal Influenza Vaccines Therapeutics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Seasonal Influenza Vaccines Therapeutics Market Outlook by Types and Applications to 2028

    • 12.1 Global Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Paediatrics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Adolescence Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Adults Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Elderly Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Seasonal Influenza Vaccines Therapeutics Market Analysis and Outlook to 2028

    • 13.1 Global Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.2 UK Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.5 France Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.3 India Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Seasonal Influenza Vaccines Therapeutics

    • Figure of Seasonal Influenza Vaccines Therapeutics Picture

    • Table Global Seasonal Influenza Vaccines Therapeutics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Seasonal Influenza Vaccines Therapeutics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Paediatrics Consumption and Growth Rate (2017-2022)

    • Figure Global Adolescence Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Elderly Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Seasonal Influenza Vaccines Therapeutics Consumption by Country (2017-2022)

    • Table North America Seasonal Influenza Vaccines Therapeutics Consumption by Country (2017-2022)

    • Figure United States Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Canada Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Seasonal Influenza Vaccines Therapeutics Consumption by Country (2017-2022)

    • Figure Germany Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure UK Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Spain Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure France Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Italy Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Finland Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Norway Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Poland Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Russia Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Table APAC Seasonal Influenza Vaccines Therapeutics Consumption by Country (2017-2022)

    • Figure China Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Table South America Seasonal Influenza Vaccines Therapeutics Consumption by Country (2017-2022)

    • Figure Brazil Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Chile Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Peru Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Table GCC Seasonal Influenza Vaccines Therapeutics Consumption by Country (2017-2022)

    • Figure Bahrain Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Oman Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Africa Seasonal Influenza Vaccines Therapeutics Consumption by Country (2017-2022)

    • Figure Nigeria Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Oceania Seasonal Influenza Vaccines Therapeutics Consumption by Country (2017-2022)

    • Figure Australia Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Seasonal Influenza Vaccines Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Hualun Biologicals Company Details

    • Table Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

    • Table Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

    • Table Novartis Seasonal Influenza Vaccines Therapeutics Product Portfolio

    • Table CSL Company Details

    • Table CSL Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

    • Table CSL Seasonal Influenza Vaccines Therapeutics Product Portfolio

    • Table Solvay Company Details

    • Table Solvay Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Solvay Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

    • Table Solvay Seasonal Influenza Vaccines Therapeutics Product Portfolio

    • Table MedImmune Company Details

    • Table MedImmune Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

    • Table MedImmune Seasonal Influenza Vaccines Therapeutics Product Portfolio

    • Table Sanofi-Pasteur Company Details

    • Table Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

    • Table Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product Portfolio

    • Table Sinovac Biotech Company Details

    • Table Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

    • Table Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product Portfolio

    • Table GSK Company Details

    • Table GSK Seasonal Influenza Vaccines Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Seasonal Influenza Vaccines Therapeutics Main Business and Markets Served

    • Table GSK Seasonal Influenza Vaccines Therapeutics Product Portfolio

    • Figure Global Paediatrics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adolescence Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Elderly Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Country (2022-2028)

    • Table North America Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Germany Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure China Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure Australia Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Seasonal Influenza Vaccines Therapeutics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.